The Impact of Systemic Disease-Associated Gingival Enlargement on Pediatric Patients

Hessam Nowzari, DDS, PhD; Sandra K. Rich, RDH, PhD

January 2008 Issue - Expires Sunday, February 28th, 2010

Compendium of Continuing Education in Dentistry


This article provides an analysis of pediatric systemic disease and the corresponding prescribed medications for selected physical and mental health conditions. The focus is on pediatric oral health, specifically the drug-associated side efffect of gingival enlargement. A simple and logical analysis of current pediatric health trends reveals that gingival overgrowth is evident in societies worldwide as a serious epidemic. this article describes the morbidity and risks that are related to drug-associated gingival overgrowth, and proposes a framework of action for treating the side effects of chronic diseases and conditions in pediatric patients.

You must be signed in to read the rest of this article.

Login Sign Up

Registration on CDEWorld is free. You may also login to CDEWorld with your account.

Learning Objectives:


The author reports no conflicts of interest associated with this work.

Queries for the author may be directed to